Ranbaxy Laboratories Ltd. (RLL) is the largest pharmaceutical company incorporated in India. It is also amongst the top league globally and is ranked 9th largest generic company worldwide. Ranbaxy is also credited with the tag of true Indian multinational. The company traces its roots to a chemist shop in Delhi. It is one of the first Indian pharmaceutical company to start a joint venture abroad. Rapid growth of Ranbaxy is attributed mainly to its focused research and joint ventures in India and abroad. It is also innovation and market driven, with a strong distribution network. The company was able to grow successfully in highly competitive markets. In the current business scenario, Ranbaxy is focusing on innovation, alliances, mergers and globalisation to achieve its long-term vision of becoming a global pharmaceutical giant with a turnover of $1 billion by 2004. The fruits of such efforts are evident in the latest financial result, as a large chunk of its income comes from new products and exports of generics. The growth of Ranbaxy can be attributed to its ability to identify good windows of opportunity and its ability to grow by leveraging innovation, regulatory knowledge and alliances.
Introduction - Business Opportunities with Ranbaxy: Core Competencies
Ranbaxy Pharmaceuticals Inc. (RPI) has already experienced commercial success penetrating the U.S. health care market, and is looking to enhance growth and future business opportunities through collaboration and strategic alliances.
Ranbaxy Pharmaceuticals Inc. (RPI) is a product-driven pharmaceutical company with diversified expertise. As a wholly owned subsidiary of Ranbaxy Laboratories Limited, India’s largest pharmaceutical company, RPI offers an advantage of having a global presence with experience in more than 125 international markets.
The company’s advanced product development and manufacturing capabilities, combined with a global sales...
Please join StudyMode to read the full document